TrumpRx is a U.S. federal government-operated website launched on February 5, 2026, by the second Trump administration (first announced in September 2025 with Pfizer CEO Albert Bourla) to deliver the "world's lowest" prescription drug prices to Americans. Rather than selling drugs directly, the site connects consumers to pharmaceutical companies—such as Pfizer, AstraZeneca, and Amgen—to purchase branded medications at discounted cash prices, bypassing insurance, and it started with just 43 drugs. However, a New York Times analysis in March 2026 found that it did not generally offer lower prices than other wealthy countries, with some popular drugs costing twice as much. The platform expanded rapidly, adding over 600 generic medications in May 2026 through partnerships with Amazon Pharmacy, GoodRx, and Cost Plus Drugs, followed by another 160 drugs in June 2026, bringing the total count to over 800. Politically, Senate Democrats like Ron Wyden dismissed it as a coupon-like marketing strategy that fails to cut overall pharmacy costs, while Bloomberg News characterized it as an instance of Trump using the federal government for shareholder activism.